Children's cancers, Sarcoma, Soft tissue sarcoma
Results
Phase 3
This trial compared doxorubicin or a combination of docetaxel and gemcitabine as the first treatment for advanced soft tissue sarcoma. It was for people whose sarcoma had spread into the surrounding body tissue, or to other parts of the body.
The trial closed in 2014 and these results were published in 2017.
Cancer Research UK supported this trial.
Recruitment start: 25 November 2010
Recruitment end: 8 January 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Beatrice Seddon
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
This is Cancer Research UK trial number CRUK/10/004.
Last reviewed: 2 July 2018
CRUK internal database number: 5089
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
